Workflow
金宇生物技术股份有限公司关于以集中竞价交易方式回购公司股份的进展公告

Core Viewpoint - The company, Jinyu Biotechnology Co., Ltd., has announced a share buyback plan to utilize its own funds for employee stock ownership plans or equity incentives, with a buyback price cap set at RMB 10.01 per share and a total buyback amount between RMB 80 million and RMB 160 million [2][4]. Group 1: Share Buyback Plan - The board of directors approved the share buyback plan on October 30, 2024, allowing the company to repurchase shares within 12 months [2]. - The buyback price was adjusted to a maximum of RMB 9.98 per share following the cash dividend distribution of RMB 0.3 per 10 shares, effective from June 26, 2025 [3]. Group 2: Buyback Progress - As of September 2025, the company had repurchased a total of 15.7133 million shares, representing 1.4134% of the total share capital, with a total expenditure of RMB 108.4854 million [4]. - The average transaction price for the shares repurchased in September 2025 was RMB 8.14 per share, with a total of 30,000 shares bought back during that month [4]. Group 3: Compliance and Future Actions - The company will adhere to relevant regulations and guidelines regarding share buybacks and will make decisions based on market conditions while fulfilling its disclosure obligations [6].